130 related articles for article (PubMed ID: 16452999)
21. ZO-1 expression shows prognostic value in chronic B cell leukemia.
Nesmiyanov PP; Tolkachev BE; Strygin AV
Immunobiology; 2016 Jan; 221(1):6-11. PubMed ID: 26306999
[TBL] [Abstract][Full Text] [Related]
22. ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemia.
Chantepie SP; Vaur D; Grunau C; Salaün V; Briand M; Parienti JJ; Heutte N; Cheze S; Roussel M; Gauduchon P; Leporrier M; Krieger S
Leuk Res; 2010 Jun; 34(6):800-8. PubMed ID: 19944462
[TBL] [Abstract][Full Text] [Related]
23. ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage.
Scielzo C; Camporeale A; Geuna M; Alessio M; Poggi A; Zocchi MR; Chilosi M; Caligaris-Cappio F; Ghia P
Leukemia; 2006 Apr; 20(4):689-95. PubMed ID: 16482211
[TBL] [Abstract][Full Text] [Related]
24. Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia.
Allan JM; Sunter NJ; Bailey JR; Pettitt AR; Harris RJ; Pepper C; Fegan C; Hall AG; Deignan L; Bacon CM; Pointon JC; Houlston RS; Broderick P; Mainou-Fowler T; Jackson GH; Summerfield G; Evans PA; Strefford JC; Parker A; Oscier D; Pratt G; Allsup DJ
Leukemia; 2010 Apr; 24(4):877-81. PubMed ID: 20090783
[No Abstract] [Full Text] [Related]
25. CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression.
Boonstra JG; van Lom K; Langerak AW; Graveland WJ; Valk PJ; Kraan J; van 't Veer MB; Gratama JW
Cytometry B Clin Cytom; 2006 May; 70(3):136-41. PubMed ID: 16568475
[TBL] [Abstract][Full Text] [Related]
26. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
27. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.
Dürig J; Nückel H; Cremer M; Führer A; Halfmeyer K; Fandrey J; Möröy T; Klein-Hitpass L; Dührsen U
Leukemia; 2003 Dec; 17(12):2426-34. PubMed ID: 14523469
[TBL] [Abstract][Full Text] [Related]
28. B lymphocytes in humans express ZAP-70 when activated in vivo.
Cutrona G; Colombo M; Matis S; Reverberi D; Dono M; Tarantino V; Chiorazzi N; Ferrarini M
Eur J Immunol; 2006 Mar; 36(3):558-69. PubMed ID: 16482508
[TBL] [Abstract][Full Text] [Related]
29. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL
Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624
[TBL] [Abstract][Full Text] [Related]
30. Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model.
Aydin S; Grabellus F; Eisele L; Möllmann M; Hanoun M; Ebeling P; Moritz T; Carpinteiro A; Nückel H; Sak A; Göthert JR; Dührsen U; Dürig J
Eur J Haematol; 2011 Jul; 87(1):10-9. PubMed ID: 21692849
[TBL] [Abstract][Full Text] [Related]
31. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Soma LA; Craig FE; Swerdlow SH
Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
[TBL] [Abstract][Full Text] [Related]
32. ZAP70 in chronic lymphocytic leukaemia.
Amin S; Parker A; Mann J
Int J Biochem Cell Biol; 2008; 40(9):1654-8. PubMed ID: 17625948
[TBL] [Abstract][Full Text] [Related]
33. Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38.
Pearce L; Morgan L; Lin TT; Hewamana S; Matthews RJ; Deaglio S; Rowntree C; Fegan C; Pepper C; Brennan P
Haematologica; 2010 Mar; 95(3):514-7. PubMed ID: 20207849
[TBL] [Abstract][Full Text] [Related]
34. Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4.
Willimott S; Baou M; Huf S; Deaglio S; Wagner SD
Haematologica; 2007 Oct; 92(10):1359-66. PubMed ID: 18024373
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.
Haferlach C; Dicker F; Schnittger S; Kern W; Haferlach T
Leukemia; 2007 Dec; 21(12):2442-51. PubMed ID: 17805327
[TBL] [Abstract][Full Text] [Related]
36. Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.
Huang L; Chen S; Zha X; Yang L; Li B; Yu Z; Wang L; Li Y
Hematology; 2012 Mar; 17(2):71-5. PubMed ID: 22664044
[TBL] [Abstract][Full Text] [Related]
37. Variations in the detection of ZAP-70 in chronic lymphocytic leukemia: Comparison with IgV(H) mutation analysis.
Sheikholeslami MR; Jilani I; Keating M; Uyeji J; Chen K; Kantarjian H; O'Brien S; Giles F; Albitar M
Cytometry B Clin Cytom; 2006 Jul; 70(4):270-5. PubMed ID: 16906585
[TBL] [Abstract][Full Text] [Related]
38. Immunoglobulin V(H) genes and CD38 expression analysis in B-cell chronic lymphocytic leukemia.
Bagli L; Zucchini A; Innoceta AM; Zaccaria A; Cipriani R; Fattori PP; Ravaioli A
Acta Haematol; 2006; 116(1):72-4. PubMed ID: 16809895
[No Abstract] [Full Text] [Related]
39. Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.
Bosch F; Muntañola A; Giné E; Carrió A; Villamor N; Moreno C; Crespo M; Montserrat E
Cytometry B Clin Cytom; 2006 Jul; 70(4):214-7. PubMed ID: 16906580
[TBL] [Abstract][Full Text] [Related]
40. ZAP-70 expression is low in normal precursor B cells or hematogones.
Davis BH; Schwartz M
Cytometry B Clin Cytom; 2006 Jul; 70(4):315-9. PubMed ID: 16906572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]